DUBLIN–(BUSINESS WIRE)–The “Global
Acne Clinical Trial Pipeline Highlights, 2019” report has been
added to ResearchAndMarkets.com’s offering.
This report provides most up-to-date information on key pipeline
products in the global Acne market. It covers emerging therapies for
Acne in active clinical development stages including early and late
stage clinical trials.
The pipeline data presented in this report helps executives in tracking
competition, identifying partners, evaluating opportunities, formulating
business development strategies, and executing in-licensing and
out-licensing deals.
Clinical Trial Stages
The report provides Acne pipeline products by clinical trial stages
including both early and late stage development – phase 3 clinical
trials, phase 2 clinical trials, phase 1 clinical trials, preclinical
research, and discovery stage.
Drug Mechanism Classes
The report provides Acne pipeline products by their dominant mechanism
of action/drug class. This helps executives categorize products based on
their drug class and also assess the strengths and weaknesses of
compounds.
Company
The report provides Acne pipeline products by the company.
Short-term Launch Highlights
Find out which Acne pipeline products will be launched in the US and
Ex-US to 2024.
Summary
- Acne phase 3 clinical trial pipeline products
- Acne phase 2 clinical trial pipeline products
- Acne phase 1 clinical trial pipeline products
- Acne preclinical research pipeline products
- Acne discovery stage pipeline products
- Acne pipeline products short-term launch highlights
List of Tables
Table 1: Acne Phase 3 Clinical Trials, 2019
Table 2: Acne Phase 2 Clinical Trials, 2019
Table 3: Acne Phase 1 Clinical Trials, 2019
Table 4: Acne Preclinical Research, 2019
Table 5: Acne Discovery Stage, 2019
List of Figures
Figure 1: Acne Pipeline Molecules by Clinical Trials Stage, 2019
Figure 2: Acne Phase 3 Clinical Trial Highlights, 2019
Figure 3: Acne Phase 2 Clinical Trial Highlights, 2019
Figure 4: Acne Phase 1 Clinical Trial Highlights, 2019
Figure 5: Acne Preclinical Research Highlights, 2019
Figure 6: Acne Discovery Stage Highlights, 2019
For more information about this report visit https://www.researchandmarkets.com/r/9tb8qm
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Clinical
Trials, Acne
Drugs